SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-078320
Filing Date
2022-03-17
Accepted
2022-03-17 16:15:36
Documents
14
Period of Report
2022-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d334735d8k.htm   iXBRL 8-K 29623
2 EX-99.1 d334735dex991.htm EX-99.1 13284
6 GRAPHIC g334735g0317182606159.jpg GRAPHIC 3409
  Complete submission text file 0001193125-22-078320.txt   175977

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nexi-20220316.xsd EX-101.SCH 2833
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20220316_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20220316_pre.xml EX-101.PRE 11243
8 EXTRACTED XBRL INSTANCE DOCUMENT d334735d8k_htm.xml XML 3340
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 22748706
SIC: 2834 Pharmaceutical Preparations